Skip to main content
TipRanks
Go Ultimate75% OFF

Franklin Genomic Advancements ETF (HELX) Price & Chart

HELX ETF Chart & Stats

$42.51
At close: 4:00 PM EST
$42$44$46Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$42.00 - $42.51
52-Week Range
$31.24 - $46.22
Previous Close
$42.96
Volume
1,291
Average Volume (3M)
5,859
AUM
34.34M
NAV
42.49
Expense Ratio
0.50%
Holdings Count
67
Beta
0.84
Inception Date
Feb 25, 2020
Shares Outstanding
800,000
Standard Deviation
N/A

ETF Overview

Franklin Genomic Advancements ETF

The Franklin Genomic Advancements ETF (HELX) is a cutting-edge investment vehicle designed for those looking to capitalize on the transformative power of genomic research and technology. As a sector-focused exchange-traded fund, HELX zeroes in on the rapidly evolving theme of genomic advancements, offering investors targeted exposure to a niche that is reshaping the future of healthcare and biotechnology. This ETF is meticulously curated to include companies at the forefront of genomic innovation, ranging from genetic sequencing pioneers to firms developing breakthrough therapies based on genetic information. HELX provides a unique opportunity to invest in the intersection of science and technology, where groundbreaking discoveries are leading to personalized medicine and novel treatments for previously untreatable conditions. With a focus on the genomic advancements sector, HELX stands out by tapping into the potential of companies that are not only pushing the boundaries of genetic research but are also poised for substantial growth in a world increasingly driven by data and precision medicine. By investing in the Franklin Genomic Advancements ETF, investors gain access to a diverse portfolio of industry leaders and emerging innovators, all of whom are committed to unlocking the secrets of the human genome to improve health outcomes globally. Whether you're a seasoned investor or new to the world of ETFs, HELX offers a compelling avenue for those looking to align their investment strategies with the future of medicine and the incredible possibilities that genomic advancements promise.

HELX ETF News

HELX ETF FAQ

What was HELX’s price range in the past 12 months?
HELX’s lowest price in the past 12 months was $31.24 and its highest was $46.22.
What is the AUM of HELX?
As of Nov 13, 2026, the AUM of HELX is $34.34M.
Is HELX overvalued?
Based on Wall Street analyst price targets for HELX’s holdings, HELX’s price is currently undervalued.
Does HELX pay dividends?
Yes. HELX pays dividends. Its most recent dividend was $0.14 per share, and its annual dividend yield is 0.34%. See more information on HELX dividends here.
How many shares outstanding does HELX have?
HELX has 800,000 shares outstanding.